Press "Enter" to skip to content

New patent for Apellis Pharms drug EMPAVELI

0
Copyright © DrugPatentWatch. Originally published at New patent for Apellis Pharms drug EMPAVELI

Annual Drug Patent Expirations for EMPAVELI
Annual Drug Patent Expirations for EMPAVELI

Empaveli is a drug marketed by Apellis Pharms and is included in one NDA. There are six patents protecting this drug.

This drug has ninety-five patent family members in twenty countries.

The generic ingredient in EMPAVELI is pegcetacoplan. Additional details are available on the pegcetacoplan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Apellis Pharms drug EMPAVELI
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions